['glaucoma', 'ocular hypertension']
['otx-tp', 'timolol']

        Inclusion Criteria:

          -  Subject must have a documented diagnosis of ocular hypertension, open angle glaucoma
             (with or without pseudoexfoliation or pigment dispersion component).

          -  Subject has a mean baseline IOP following washout in at least 1 eye (the same eye) of

             ≥ 24mmHg at Hour 0 (T0) at Baseline Visit 1 and Baseline Visit 2 (Day 1)

          -  Subject has a mean baseline IOP following washout in at least 1 eye (the same eye) of:

             ≥ 22mmHg at (T0 + 4h) and (T0 + 8h) at Baseline Visit 1 (note: the same eye must meet
             the IOP eligibility criteria at all 4 baseline assessments)

          -  Washout IOP must be ≤ 34mmHg in each eye at all time points at the Baseline Visit 1
             and Baseline Visit 2 (Day 1)

        Exclusion Criteria:

          -  Subject with any form of glaucoma other than open angle glaucoma (with or without a
             pigment dispersion or pseudoexfoliation component).

          -  Subject with mean baseline IOP >34 mmHg in either eye at any time point during the
             Baseline Visits 1 or 2 (Day 1).

          -  Subject with a BCVA worse than 0.6 logMAR (20/80 Snellen) in either eye as measured
             using an ETDRS chart.

          -  Subject with a known or suspected allergy and/or hypersensitivity to travoprost,
             timolol, fluorescein or to any component of the study products.
      